V.P.M. van Empel
-
Tobal, R., Potjewijd, J., van Doorn, D. P. C., van Empel, V., Damoiseaux, J., & van Paassen, P. (2024). High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension. Diagnostics, 14(14), Article 1471. https://doi.org/10.3390/diagnostics14141471More information about this publication
-
Nebhwani, M., Chaibekava, K., Achten, A., Oerlemans, M. I. F. J., Michels, M., van der Meer, P., Nienhuis, H. L. A., Weerts, J., van Empel, V., Rocca, H. P. B. L., Wijk, S. S. V., van der Pol, J., & Knackstedt, C. (2024). Detection of cardiac amyloidosis on routine bone scintigraphy: an important gatekeeper role for the nuclear medicine physician. International Journal of Cardiovascular Imaging, 40(6), 1183-1192. https://doi.org/10.1007/s10554-024-03085-zMore information about this publication
-
Carland, C., Zhao, L., Salman, O., Cohen, J. B., Zamani, P., Xiao, Q., Dongre, A., Wang, Z., Ebert, C., Greenawalt, D., van Empel, V., Richards, A. M., Doughty, R. N., Rietzschel, E., Javaheri, A., Wang, Y., Schafer, P. H., Hersey, S., Carayannopoulos, L. N., ... Chirinos, J. A. (2024). Urinary Proteomics and Outcomes in Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association, 13(9), e033410. Article 033410. https://doi.org/10.1161/JAHA.123.033410More information about this publication
-
Muller, S. A., Achten, A., van der Meer, M. G., Zwetsloot, P.-P., Sanders-van Wijk, S., van der Harst, P., van Tintelen, J. P., te Riele, A. S. J. M., van Empel, V., Knackstedt, C., & Oerlemans, M. I. F. J. (2024). Absence of an increased wall thickness does not rule out cardiac amyloidosis. Amyloid-journal of Protein Folding Disorders. Advance online publication. https://doi.org/10.1080/13506129.2024.2348681More information about this publication
-
Achten, A., van Empel, V. P. M., Weerts, J., Mourmans, S., Beckers-Wesche, F., Spanjers, M., Gingele, A., Brunner-La Rocca, H.-P., Sanders-van Wijk, S., & Knackstedt, C. (2024). Changes in the diagnostic trajectory of transthyretin cardiac amyloidosis over six years. Heart and Vessels. Advance online publication. https://doi.org/10.1007/s00380-024-02408-3More information about this publication
-
Verdonschot, J. A. J., Hellebrekers, D. M. E. I., van Empel, V. P. M., Heijligers, M., de Munnik, S., Coonen, E., Dreesen, J. C. M. F., van den Wijngaard, A., Brunner, H. G., Zamani Esteki, M., Heymans, S. R. B., de Die-Smulders, C. E. M., & Paulussen, A. D. C. (2024). Clinical Guideline for Preimplantation Genetic Testing in Inherited Cardiac Diseases. Circulation: Genomic and Precision Medicine, 17(2), Article E004416. https://doi.org/10.1161/CIRCGEN.123.004416More information about this publication
-
Dib, M.-J., Levin, M. G., Zhao, L., Diab, A., Wang, Z., Ebert, C., Salman, O., Azzo, J. D., Gan, S., Zamani, P., Cohen, J. B., Gill, D., Burgess, S., Zagkos, L., van Empel, V., Richards, A. M., Doughty, R., Rietzschel, E. R., Kammerhoff, K., ... Chirinos, J. A. (2024). Proteomic Associations of Adverse Outcomes in Human Heart Failure. Journal of the American Heart Association, 13(5), Article e031154. https://doi.org/10.1161/JAHA.123.031154More information about this publication
-
Tubben, A., Tingen, H. S. A., Prakken, N. H. J., van Empel, V. P. M., Gorter, T. M., Meems, L. M. G., Manintveld, O. C., Rienstra, M., Tieleman, R. G., Glaudemans, A. W. J. M., van Veldhuisen, D. J., Slart, R. H. J. A., Nienhuis, H. L. A., & van der Meer, P. (2024). Prevalence of wild-type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo-VIP-HF study. European journal of heart failure, 26(3), 695-698. https://doi.org/10.1002/ejhf.3186More information about this publication
-
Azzo, J. D., Dib, M.-J., Zagkos, L., Zhao, L., Wang, Z., Chang, C.-P., Ebert, C., Salman, O., Gan, S., Zamani, P., Cohen, J. B., van Empel, V., Richards, A. M., Javaheri, A., Mann, D. L., Rietzschel, E. R., Schafer, P. H., Seiffert, D. A., Gill, D., ... Chirinos, J. A. (2024). Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection Fraction. Circulation-Heart Failure, 17(2), Article e011146. https://doi.org/10.1161/CIRCHEARTFAILURE.123.011146More information about this publication
-
Clephas, P. R. D., Malgie, J., Schaap, J., Koudstaal, S., Emans, M., Linssen, G. C. M., de Boer, G. A., van Heerebeek, L., Borleffs, C. J. W., Manintveld, O. C., van Empel, V., van Wijk, S., van den Heuvel, M., da Fonseca, C., Damman, K., van Ramshorst, J., van Kimmenade, R., van de Ven, A. R. T., Tio, R. A., ... Brugts, J. J. (2024). Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE-HF. Esc heart failure, 11(1), 550-559. https://doi.org/10.1002/ehf2.14604More information about this publication
V.P.M. van Empel
Associate Professor
Cardiologie
School for Cardiovascular Diseases
Fac. Health, Medicine and Life Sciences